Literature DB >> 25121745

Collateral damage: microbiota-derived metabolites and immune function in the antibiotic era.

Christopher A Lopez1, Dawn D Kingsbury1, Eric M Velazquez1, Andreas J Bäumler2.   

Abstract

Our long-standing evolutionary association with gut-associated microbial communities has given rise to an intimate relationship, which affects many aspects of human health. Recent studies on the mechanisms that link these microbial communities to immune education, nutrition, and protection against pathogens point to microbiota-derived metabolites as key players during these microbe-host interactions. A disruption of gut-associated microbial communities by antibiotic treatment can result in a depletion of microbiota-derived metabolites, thereby enhancing pathogen susceptibility, impairing immune homeostasis, and contributing to the rise of certain chronic inflammatory diseases. Here, we highlight some of the recently elucidated mechanisms that showcase the impacts of microbiota-derived metabolites on human health.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25121745      PMCID: PMC4151313          DOI: 10.1016/j.chom.2014.07.009

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  97 in total

1.  Antibacterial mechanisms of the mouse gut. II. The role of Eh and volatile fatty acids in the normal gut.

Authors:  G G MEYNELL
Journal:  Br J Exp Pathol       Date:  1963-04

2.  Disappearing microbiota: Helicobacter pylori protection against esophageal adenocarcinoma.

Authors:  Martin J Blaser
Journal:  Cancer Prev Res (Phila)       Date:  2008-10

3.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells.

Authors:  Yukihiro Furusawa; Yuuki Obata; Shinji Fukuda; Takaho A Endo; Gaku Nakato; Daisuke Takahashi; Yumiko Nakanishi; Chikako Uetake; Keiko Kato; Tamotsu Kato; Masumi Takahashi; Noriko N Fukuda; Shinnosuke Murakami; Eiji Miyauchi; Shingo Hino; Koji Atarashi; Satoshi Onawa; Yumiko Fujimura; Trevor Lockett; Julie M Clarke; David L Topping; Masaru Tomita; Shohei Hori; Osamu Ohara; Tatsuya Morita; Haruhiko Koseki; Jun Kikuchi; Kenya Honda; Koji Hase; Hiroshi Ohno
Journal:  Nature       Date:  2013-11-13       Impact factor: 49.962

Review 4.  Eating for two: how metabolism establishes interspecies interactions in the gut.

Authors:  Michael A Fischbach; Justin L Sonnenburg
Journal:  Cell Host Microbe       Date:  2011-10-20       Impact factor: 21.023

5.  Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract.

Authors:  Ivan Monteleone; Angelamaria Rizzo; Massimiliano Sarra; Giuseppe Sica; Pierpaolo Sileri; Livia Biancone; Thomas T MacDonald; Francesco Pallone; Giovanni Monteleone
Journal:  Gastroenterology       Date:  2011-04-16       Impact factor: 22.682

6.  Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis.

Authors:  Aurélien Trompette; Eva S Gollwitzer; Koshika Yadava; Anke K Sichelstiel; Norbert Sprenger; Catherine Ngom-Bru; Carine Blanchard; Tobias Junt; Laurent P Nicod; Nicola L Harris; Benjamin J Marsland
Journal:  Nat Med       Date:  2014-01-05       Impact factor: 53.440

7.  Expression of the human aryl hydrocarbon receptor complex in yeast. Activation of transcription by indole compounds.

Authors:  C A Miller
Journal:  J Biol Chem       Date:  1997-12-26       Impact factor: 5.157

8.  Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43.

Authors:  Kendle M Maslowski; Angelica T Vieira; Aylwin Ng; Jan Kranich; Frederic Sierro; Di Yu; Heidi C Schilter; Michael S Rolph; Fabienne Mackay; David Artis; Ramnik J Xavier; Mauro M Teixeira; Charles R Mackay
Journal:  Nature       Date:  2009-10-29       Impact factor: 49.962

9.  Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA.

Authors:  Denise Kelly; Jamie I Campbell; Timothy P King; George Grant; Emmelie A Jansson; Alistair G P Coutts; Sven Pettersson; Shaun Conway
Journal:  Nat Immunol       Date:  2003-12-21       Impact factor: 25.606

10.  The intestinal microbiota plays a role in Salmonella-induced colitis independent of pathogen colonization.

Authors:  Rosana B R Ferreira; Navkiran Gill; Benjamin P Willing; L Caetano M Antunes; Shannon L Russell; Matthew A Croxen; B Brett Finlay
Journal:  PLoS One       Date:  2011-05-25       Impact factor: 3.240

View more
  21 in total

1.  Sulfamethoxazole drug stress upregulates antioxidant immunomodulatory metabolites in Escherichia coli.

Authors:  Hyun Bong Park; Zheng Wei; Joonseok Oh; Hao Xu; Chung Sub Kim; Rurun Wang; Thomas P Wyche; Grazia Piizzi; Richard A Flavell; Jason M Crawford
Journal:  Nat Microbiol       Date:  2020-07-27       Impact factor: 17.745

Review 2.  Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation.

Authors:  Anastasia I Petra; Smaro Panagiotidou; Erifili Hatziagelaki; Julia M Stewart; Pio Conti; Theoharis C Theoharides
Journal:  Clin Ther       Date:  2015-05-01       Impact factor: 3.393

3.  Early airway microbial metagenomic and metabolomic signatures are associated with development of severe bronchopulmonary dysplasia.

Authors:  Charitharth Vivek Lal; Jegen Kandasamy; Kalsang Dolma; Manimaran Ramani; Ranjit Kumar; Landon Wilson; Zubair Aghai; Stephen Barnes; J Edwin Blalock; Amit Gaggar; Vineet Bhandari; Namasivayam Ambalavanan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-08-16       Impact factor: 5.464

Review 4.  Targeting friend and foe: Emerging therapeutics in the age of gut microbiome and disease.

Authors:  Jin Ah Cho; Daniel J F Chinnapen
Journal:  J Microbiol       Date:  2018-02-28       Impact factor: 3.422

Review 5.  The germ-organ theory of non-communicable diseases.

Authors:  Mariana X Byndloss; Andreas J Bäumler
Journal:  Nat Rev Microbiol       Date:  2018-01-08       Impact factor: 60.633

6.  Gut microbiomes and their metabolites shape human and animal health.

Authors:  Woojun Park
Journal:  J Microbiol       Date:  2018-03       Impact factor: 3.422

Review 7.  Determining microbial products and identifying molecular targets in the human microbiome.

Authors:  Regina Joice; Koji Yasuda; Afrah Shafquat; Xochitl C Morgan; Curtis Huttenhower
Journal:  Cell Metab       Date:  2014-11-04       Impact factor: 27.287

8.  Long-term effects on luminal and mucosal microbiota and commonly acquired taxa in faecal microbiota transplantation for recurrent Clostridium difficile infection.

Authors:  Jonna Jalanka; Eero Mattila; Hanne Jouhten; Jorn Hartman; Willem M de Vos; Perttu Arkkila; Reetta Satokari
Journal:  BMC Med       Date:  2016-10-11       Impact factor: 8.775

9.  Comparison of gut microbiota in autism spectrum disorders and neurotypical boys in China: A case-control study.

Authors:  Fang Ye; Xinying Gao; Zhiyi Wang; Shuman Cao; Guangcai Liang; Danni He; Zhitang Lv; Liming Wang; Pengfei Xu; Qi Zhang
Journal:  Synth Syst Biotechnol       Date:  2021-05-21

10.  Lactobacillus reuteri I5007 Modulates Intestinal Host Defense Peptide Expression in the Model of IPEC-J2 Cells and Neonatal Piglets.

Authors:  Hongbin Liu; Chengli Hou; Gang Wang; Hongmin Jia; Haitao Yu; Xiangfang Zeng; Philip A Thacker; Guolong Zhang; Shiyan Qiao
Journal:  Nutrients       Date:  2017-05-31       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.